TABLE 2.
SNP | Genotype | PR | 95% CI | P2 | Global P3 | |
rs735877 | AG vs. GG | 1.10 | 0.96 | 1.27 | 0.16 | 0.37 |
AA vs. GG | 1.05 | 0.87 | 1.27 | 0.60 | ||
rs1502593 | CT vs. CC | 1.22 | 1.03 | 1.44 | 0.02 | 0.03 |
TT vs. CC | 1.24 | 1.01 | 1.52 | 0.04 | ||
rs11190483 | CT vs. CC | 0.94 | 0.83 | 1.07 | 0.38 | 0.33 |
TT vs. CC | 1.11 | 0.90 | 1.36 | 0.34 | ||
rs3071 | GT vs. TT | 1.00 | 0.88 | 1.14 | 0.98 | 0.51 |
GG vs. TT | 1.14 | 0.91 | 1.43 | 0.24 | ||
rs11557927 | GT vs. TT | 1.00 | 0.86 | 1.17 | 0.98 | 0.36 |
GG vs. TT | 0.56 | 0.21 | 1.53 | 0.26 | ||
rs508384 | AC vs. CC | 0.96 | 0.84 | 1.10 | 0.57 | 0.77 |
AA vs. CC | 1.06 | 0.77 | 1.47 | 0.71 | ||
rs1393491 | CT vs. TT | 0.94 | 0.83 | 1.07 | 0.37 | 0.63 |
CC vs. TT | 1.03 | 0.74 | 1.44 | 0.85 |
PR, prevalence ratio; MetS, metabolic syndrome; SNP, single nucleotide polymorphism. Co-dominant genetic models were carried out; adjusted for individual admixture proportion and age.
P was 2-sided.
Global is from score test.